BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 19049939)

  • 1. Paraneoplastic pemphigus despite treatment with rituximab, fludarabine and cyclophosphamide in chronic lymphocytic leukemia.
    Schierl M; Foedinger D; Geissler K; Rappersberger K; Feldmann R
    Eur J Dermatol; 2008; 18(6):717-8. PubMed ID: 19049939
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel case of IgA paraneoplastic pemphigus associated with chronic lymphocytic leukemia.
    Taintor AR; Leiferman KM; Hashimoto T; Ishii N; Zone JJ; Hull CM
    J Am Acad Dermatol; 2007 May; 56(5 Suppl):S73-6. PubMed ID: 17434044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variations on the fludarabine, cyclophosphamide, and rituximab combination in chronic lymphocytic leukemia therapy: what have we learned?
    Ahmadi T; Schuster SJ
    J Clin Oncol; 2009 Feb; 27(4):479-80. PubMed ID: 19075263
    [No Abstract]   [Full Text] [Related]  

  • 4. Early and late infectious consequences of adding rituximab to fludarabine and cyclophosphamide in patients with indolent lymphoid malignancies.
    Tam C; Seymour JF; Brown M; Campbell P; Scarlett J; Underhill C; Ritchie D; Bond R; Grigg AP
    Haematologica; 2005 May; 90(5):700-2. PubMed ID: 15921393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct antiglobulin test negative autoimmune haemolytic anaemia associated with fludarabine/cyclophosphamide/rituximab therapy.
    Garratty G; Petz LD
    Br J Haematol; 2007 Nov; 139(4):622-3. PubMed ID: 17979948
    [No Abstract]   [Full Text] [Related]  

  • 6. Changing the way we think about chronic lymphocytic leukemia.
    Lin TS; Grever MR; Byrd JC
    J Clin Oncol; 2005 Jun; 23(18):4009-12. PubMed ID: 15767640
    [No Abstract]   [Full Text] [Related]  

  • 7. Lichenoid paraneoplastic pemphigus in the absence of detectable antibodies.
    Cummins DL; Mimouni D; Tzu J; Owens N; Anhalt GJ; Meyerle JH
    J Am Acad Dermatol; 2007 Jan; 56(1):153-9. PubMed ID: 17097371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL.
    Heizmann M; Itin P; Wernli M; Borradori L; Bargetzi MJ
    Am J Hematol; 2001 Feb; 66(2):142-4. PubMed ID: 11421295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraneoplastic erythropoietin-induced polycythemia associated with small lymphocytic lymphoma.
    Al-Tourah AJ; Tsang PW; Skinnider BF; Hoskins PJ
    J Clin Oncol; 2006 May; 24(15):2388-9. PubMed ID: 16710039
    [No Abstract]   [Full Text] [Related]  

  • 10. [Successful combined treatment with rituximab and high dose immunoglobulin in a patient with chronic lymphocytic leukemia with fludarabine-induced severe immune thrombocytopenia].
    Telek B; Batár P; Uvardy M
    Orv Hetil; 2005 Aug; 146(34):1791-3. PubMed ID: 16184881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoimmunotherapy with low-dose fludarabine and cyclophosphamide and high dose rituximab in previously untreated patients with chronic lymphocytic leukemia.
    Foon KA; Boyiadzis M; Land SR; Marks S; Raptis A; Pietragallo L; Meisner D; Laman A; Sulecki M; Butchko A; Schaefer P; Lenzer D; Tarhini A
    J Clin Oncol; 2009 Feb; 27(4):498-503. PubMed ID: 19075274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab, fludarabine, cyclophosphamide, and mitoxantrone: a new, highly active chemoimmunotherapy regimen for chronic lymphocytic leukemia.
    Bosch F; Abrisqueta P; Villamor N; Terol MJ; González-Barca E; Ferra C; González Diaz M; Abella E; Delgado J; Carbonell F; García Marco JA; Escoda L; Ferrer S; Monzó E; González Y; Estany C; Jarque I; Salamero O; Muntañola A; Montserrat E
    J Clin Oncol; 2009 Sep; 27(27):4578-84. PubMed ID: 19704063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring for cytomegalovirus and Epstein-Barr virus infection in chronic lymphocytic leukemia patients receiving i.v. fludarabine-cyclophosphamide combination and alemtuzumab as consolidation therapy.
    Orlandi EM; Baldanti F; Citro A; Pochintesta L; Gatti M; Lazzarino M
    Haematologica; 2008 Nov; 93(11):1758-60. PubMed ID: 18790800
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab--incidence and predictors.
    Borthakur G; O'Brien S; Wierda WG; Thomas DA; Cortes JE; Giles FJ; Kantarjian HM; Lerner S; Keating MJ
    Br J Haematol; 2007 Mar; 136(6):800-5. PubMed ID: 17341265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive multifocal leukencephalopathy and cerebral toxoplasmosis in a patient with CLL.
    Desmond R; Lynch K; Gleeson M; Farrell M; Murphy P
    Am J Hematol; 2010 Aug; 85(8):607. PubMed ID: 20029990
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of chronic lymphocytic leukemia with regimen of fludarabine, cyclophosphamide and rituximab].
    Gu WJ; Xu W; Qian SX; Wu YJ; Hong M; Chen LJ; Wu HX; Lu H; Qiu HX; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):938-42. PubMed ID: 18718095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment-related acute myeloid leukemia with 11q23 translocation following treatment with fludarabine, cyclophosphamide and rituximab.
    Martin-Salces M; Canales MA; de Paz R; Hernandez-Navarro F
    Leuk Res; 2008 Jan; 32(1):199-200. PubMed ID: 17870157
    [No Abstract]   [Full Text] [Related]  

  • 18. Low-dose thalidomide in combination with oral fludarabine and cyclophosphamide is ineffective in heavily pretreated patients with chronic lymphocytic leukemia.
    Giannopoulos K; Dmoszyńska A; Roliński J
    Leuk Res; 2007 Mar; 31(3):411-2. PubMed ID: 16978694
    [No Abstract]   [Full Text] [Related]  

  • 19. Progressive respiratory failure in paraneoplastic pemphigus associated with chronic lymphocytic leukemia.
    Brönnimann M; von Felbert V; Streit M; Hunziker T; Braathen LR
    Dermatology; 2004; 208(3):251-4. PubMed ID: 15118381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997.
    Flinn IW; Neuberg DS; Grever MR; Dewald GW; Bennett JM; Paietta EM; Hussein MA; Appelbaum FR; Larson RA; Moore DF; Tallman MS
    J Clin Oncol; 2007 Mar; 25(7):793-8. PubMed ID: 17283364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.